| Year |
Citation |
Score |
| 2004 |
Landen JW, Hau V, Wang M, Davis T, Ciliax B, Wainer BH, Van Meir EG, Glass JD, Joshi HC, Archer DR. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5187-201. PMID 15297423 DOI: 10.1158/1078-0432.Ccr-04-0360 |
0.594 |
|
| 2004 |
Hau VS, Huber JD, Campos CR, Davis RT, Davis TP. Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Research. 1018: 257-64. PMID 15276886 DOI: 10.1016/J.Brainres.2004.05.081 |
0.736 |
|
| 2002 |
Huber JD, Hau VS, Borg L, Campos CR, Egleton RD, Davis TP. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology. 283: H1531-7. PMID 12234806 DOI: 10.1152/Ajpheart.00027.2002 |
0.695 |
|
| 2002 |
Hau VS, Huber JD, Campos CR, Lipkowski AW, Misicka A, Davis TP. Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. Journal of Pharmaceutical Sciences. 91: 2140-9. PMID 12226841 DOI: 10.1002/Jps.10202 |
0.695 |
|
| 2002 |
Huber JD, Hau VS, Mark KS, Brown RC, Campos CR, Davis TP. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant. European Journal of Pharmacology. 450: 297-304. PMID 12208323 DOI: 10.1016/S0014-2999(02)02150-7 |
0.646 |
|
| 1999 |
Hau VS, Campos C, Hoshata K, Lipokowski A, Yamamura HI, Hruby VJ, Davis TP. Guanidino cationization effects on the blood-brain barrier permeability, in vitro stability and receptor binding of endomorphins Journal of Investigative Medicine. 47: 34A. |
0.545 |
|
| 1998 |
Kline JP, Bell I, Schwartz GE, Hau V, Davis T. Repressive and defensive coping styles predict resting plasma endorphin levels in the elderly. Biological Psychology. 49: 295-302. PMID 9858058 DOI: 10.1016/S0301-0511(98)00048-9 |
0.421 |
|
| 1997 |
Thomas SA, Abbruscato TJ, Hau VS, Gillespie TJ, Zsigo J, Hruby VJ, Davis TP. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability. The Journal of Pharmacology and Experimental Therapeutics. 281: 817-25. PMID 9152390 |
0.515 |
|
| 1997 |
Bell IR, Schwartz GE, Bootzin RR, Hau V, Davis TP. Elevation of plasma beta-endorphin levels of shy elderly in response to novel laboratory experiences. Behavioral Medicine (Washington, D.C.). 22: 168-73. PMID 9138625 DOI: 10.1080/08964289.1997.10543550 |
0.392 |
|
| 1996 |
Bell IR, Bootzin RR, Davis TP, Hau V, Ritenbaugh C, Johnson KA, Schwartz GE. Time-dependent sensitization of plasma beta-endorphin in community elderly with self-reported environmental chemical odor intolerance. Biological Psychiatry. 40: 134-43. PMID 8793045 DOI: 10.1016/0006-3223(95)00331-2 |
0.386 |
|
| 1996 |
Greene DL, Hau VS, Abbruscato TJ, Bartosz H, Misicka A, Lipkowski AW, Hom S, Gillespie TJ, Hruby VJ, Davis TP. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability. The Journal of Pharmacology and Experimental Therapeutics. 277: 1366-75. PMID 8667199 |
0.714 |
|
| Show low-probability matches. |